Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Brazilians seek US carbendazim phase-out deal

Brazilian orange juice exporters have called on the Ministry of Agriculture to request the US authorities to agree a phase-out of use of carbendazim on oranges destined for export to the country. Orange growers in the Brazilian state of Sao Paulo are already switching fungicide applications away from carbendazim, Brazilian newspaper Globo reports. President of the Ministry-linked chamber of citrus crops, Marco Antônio dos Santos, says that a trend is already under way in which growers are substituting applications from the active ingredient for others that are acceptable to US importers. The US authorities began testing imported juice after notification of the presence of the ai, which is not permitted in US juice, in produce from Brazil and further imports from Brazil and Canada have since been seized (see this issue). The US authorities have reportedly indicated that a decision will be taken shortly on whether to accept a proposed 18-month phase-out for use of the ai in orchards. Brazil dominates such imports into the US.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts